Biopharmaceuticals Market

Biopharmaceuticals Market Size, Trends & Forecast (2019 - 2025)

Biopharmaceuticals Market is promised to have a steady pace over the foremost time span.  The biopharmaceuticals market is projected to reach USD 523,001 million by 2025, registering a CAGR of 13% from 2019 to 2025.

Biopharmaceuticals are drugs manufactured through the extraction from biological sources. Through different processes, pharmaceutical synthesis includes, vaccines, blood components, allergenic and living cells in the. Mostly, high-cost drugs are the products extracted from biological sources. These drugs have fewer side effects compared with the other kind of medicines to their synthesis process. Terms with biopharmaceuticals vary with the groups and also have different formulations.

Market Dynamics:

• Growing incidences of cardiovascular and other chronic diseases especially in elderly people are a key driving factor for the market. Rise in the disposable income in urbanized areas is additionally lavishing the demand of the market.
• However, fluctuations in the availability of raw materials for manufacturing final products are slightly restraining the growth of the market. The cost of these medicines is a bit expensive which cannot be affordable by common people is remained a challenging factor for the market growth.
• On-going research on manufacturing innovative drugs to promote effective treatment with fewer or no side effects is surging growth opportunities for the market. Increased investments by the government are also escalating the growth of the market.

Key takeaways from the report:

• Analysis of the current and future trends and growth potential of the market during the forecast period
• Evaluate market potential in terms of growth rates (CAGR), Value (USD) and Volume (Units) sales at a country level across various segments of the market
• Understand the market dynamics and key influencers in terms of driving factors and opportunities of the market. Also, restraints and challenges that the industry has to endure
• Insights on competitor performance with a benchmarking analysis of their market position, financials and more
• Profiles of key market players providing a comprehensive understanding of their product portfolio, SWOT analysis, and growth strategies
• Information on key events in the recent past which includes mergers & acquisition, new product launches, collaborations, deals, and other agreements
• Analysis of the supply-demand gap, import-export statistics, and other key market insights for more than 20 countries globally
• Gauge the competition in the industry with Porter's five force analysis understanding the threat from new entrants and substitute products.
• Understand the effects of macro-level environment factors through the PESTLE analysis, providing a detailed assessment of the external factors that have an impact on the industry

This research report includes following segmentation for the Global Biopharmaceuticals Market:

Biopharmaceuticals Market Analysis - By Product

• Monoclonal antibody
• Interferon
• Insulin
• Growth and coagulation factor
• Erythropoietin
• Vaccine
• Hormone
• Others

Based on the Product, Monoclonal antibody segment is having tremendous growth rate from recent years.

Biopharmaceuticals Market Analysis - By Application

• Oncology
• Blood disorder
• Metabolic disease
• Infectious disease
• Cardiovascular disease
• Neurological disease
• Immunology
• Others

By Application, the Oncology sector is leading with the highest shares of the market.

Biopharmaceuticals Market Analysis - By Region

• North America

  • U.S.
  • Canada
  • Mexico

• Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

• Asia-Pacific

  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific

• Latin America, Middle East and Africa

  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Regionally, the market is categorized into Asia Pacific, Europe, North America, and Middle East & Africa. Asia pacific is positioned top in holding the dominant shares of the market by owing to the increasing geriatric population and also growing support from the government through investments in the medical sector. North America and Europe are anticipated to lead the highest shares of the market next to the Asia Pacific. Middle East & Africa are deemed to have a prominent growth rate in the forecast period.

Top companies dominating the Global Biopharmaceuticals Market profiled in this report are:

1. Abbott Laboratories
2.  Amgen, Inc.
3.  Biogen, Inc.
4.  Eli Lilly and Company
5.  F. Hoffmann-La Roche, Ltd.
6.  Johnson & Johnson
7.  Merck & Co., Inc.
8. Novo Nordisk A/S
9.  Pfizer, Inc.
10.  Sanofi
11. Bristol Myers Squibb Company
12. Bayer AG
13.  Shire plc